SCHEMBL6971207

SCHEMBL6971207

COc1ccc(C2(C(=O)O)OCC(c3ccccc3)(c3ccccc3)CO2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.44
OPRL1 P41146 2/20 0.44
MAPT P10636 3/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPK1 P28482 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
CHRND Q07001 1/20 0.38
F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971971 0.87 NPC1 (0.44) OPRM1OPRL1MAPTRAB9ANPC1
SCHEMBL6981777 0.86 AKR1C1 (0.41) OPRM1OPRL1KMT2AMAPK1L3MBTL1
SCHEMBL6981106 0.84 APP (0.43) OPRM1OPRL1MAPTKMT2AL3MBTL1
SCHEMBL6978477 0.84 LMNA (0.39) OPRM1OPRL1RAB9ANPC1KMT2A
SCHEMBL6982594 0.81 HSD11B1 (0.39) RAB9ANPC1KMT2ACHRNA1CHRNG
SCHEMBL6967893 0.81 CNR1 (0.40) MAPTKMT2AMAPK1CES2CES1
SCHEMBL20091128 0.79 CES2 (0.51) OPRM1OPRL1MAPTRAB9ANPC1
SCHEMBL6981080 0.77 THRB (0.44) OPRM1OPRL1RAB9ANPC1CES2
SCHEMBL20091138 0.76 CES2 (0.55) OPRM1OPRL1MAPTRAB9ANPC1
SCHEMBL6984599 0.76 RXRA (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed